Education
About Us
Working with TipRanks
Follow Us
Minerva Neurosciences (NERV)
NASDAQ:NERV
Total Valuation
Minerva Neurosciences has a market cap or net worth of $11.61M. The enterprise value is $55.35M.
Market Cap$11.61M
Enterprise Value$55.35M
Share Statistics
Minerva Neurosciences has 6,993,406 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,993,406
Owned by Insiders6.80%
Owned by Institutions0.29%
Financial Efficiency
Minerva Neurosciences’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -0.06%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)-0.06%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee0.00
Profits Per Employee179.86M
Employee Count8
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Minerva Neurosciences is 11.68. Minerva Neurosciences’s PEG ratio is -0.11.
PE Ratio11.68
PS Ratio―
PB Ratio>-0.01
Price to Fair Value>-0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio-0.11
Income Statement
In the last 12 months, Minerva Neurosciences had revenue of 0.00 and earned 1.44M in profits. Earnings per share was 0.19.
Revenue0.00
Gross Profit0.00
Operating Income-21.85M
Pretax Income1.44B
Net Income1.44M
EBITDA-21.85B
Earnings Per Share (EPS)0.19
Cash Flow
In the last 12 months, operating cash flow was -14.38T and capital expenditures 0.00, giving a free cash flow of -14.38T billion.
Operating Cash Flow-14.38T
Free Cash Flow-14.38T
Free Cash Flow per Share-2.06M
Dividends & Yields
Minerva Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.53
52-Week Price Change-32.14%
50-Day Moving Average1.68
200-Day Moving Average2.34
Relative Strength Index (RSI)56.31
Average Volume (3m)16.48K
Important Dates
Minerva Neurosciences upcoming earnings date is May 13, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend Date―
Financial Position
Minerva Neurosciences as a current ratio of 7.85K, with Debt / Equity ratio of 0.00%
Current Ratio7.85K
Quick Ratio7.85K
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio-4.79
Taxes
In the past 12 months, Minerva Neurosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Minerva Neurosciences EV to EBITDA ratio is <0.01, with an EV/FCF ratio of <0.01.
EV to Sales0.00
EV to EBITDA<0.01
EV to Free Cash Flow<0.01
EV to Operating Cash Flow<0.01
Balance Sheet
Minerva Neurosciences has $21.36M in cash and marketable securities with $832.58K in debt, giving a net cash position of -$21.36M billion.
Cash & Marketable Securities$21.36M
Total Debt$832.58K
Net Cash-$21.36M
Net Cash Per Share-$3.05
Tangible Book Value Per Share-$5.36K
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Minerva Neurosciences is $5.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$5.00
Price Target Upside192.40% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―